πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12427160

Use of cannabinoids in the treatment of epilepsy

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12403136

Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation th

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12396963

Cannabidiol-type cannabinoid compound

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12383567

Use of cannabinoids in the treatment of epilepsy

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12383512

Cannabidiol-type cannabinoid compound

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12364670

Cannabidiol-type cannabinoid compound

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12357586

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epilepti

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12350253

Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12318356

Use of cannabinoids in the treatment of epilepsy

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12263139

Use of cannabidiol in the treatment of tuberous sclerosis complex

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12213985

Oral cannabinoid formulations

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12161607

Combination of cannabinoids in the treatment of leukemia

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12102619

Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12064398

Parenteral formulations

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12064399

Use of cannabinoids in the treatment of epilepsy

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted